Screener
10x Genomics, Inc. TXG Market capitalization
Market capitalization at other companies
Other financials
Where this comes from
Computed from the period-end share price: $4.87B.
The source filing: 10x Genomics, Inc.’s 10-Q, filed August 7, 2026. Open the filing →
- Filed
- Aug 6, 2026, 8:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-054491
FAQ
- What is 10x Genomics, Inc.'s market capitalization?
- 10x Genomics, Inc. (TXG) reported market capitalization of $4.87B in Q2 2026.
- How has 10x Genomics, Inc.'s market capitalization changed year-over-year?
- 10x Genomics, Inc.'s market capitalization increased by 263.0% year-over-year, from $1.34B to $4.87B.
- What is the long-term trend for 10x Genomics, Inc.'s market capitalization?
- Over 5 years (2020 to 2025), 10x Genomics, Inc.'s market capitalization has grown at a -33.5% compound annual growth rate (CAGR), from $15.82B to $2.06B.
- What does market capitalization mean?
- The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.
Ask your AI about 10x Genomics, Inc.'s market capitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude